KD Logo

Insider Selling: Dubovsky Filip, Novavax, Inc. [NVAX] President, R&D divested 13,904 shares

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Novavax, Inc. shares valued at $201,164 were sold by Dubovsky Filip on Jun 17 ’24. At $14.47 per share, Dubovsky Filip sold 13,904 shares. The insider’s holdings dropped to 66,613 shares worth approximately $0.94 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Also, Dubovsky Filip sold 47,312 shares, netting a total of over 657,637 in proceeds. Following the sale of shares at $13.90 each, the insider now holds 38,953 shares.

As published in a research note from JP Morgan on May 10, 2024, Novavax, Inc. [NVAX] has been rated up from an Underweight to a Neutral. Analysts at BofA Securities upgraded the stock from ‘”an Underperform”‘ to ‘”a Neutral”‘ outlook in a report released in early May. As of August 09, 2023, B. Riley Securities has increased its “Neutral” rating to a “Buy” for NVAX. Earlier on April 20, 2023, TD Cowen downgraded its rating. Their new recommendation was “a Market perform” for NVAX stock which previously was a “an Outperform”.

Analyzing NVAX Stock Performance

During the last five days, there has been a drop of approximately -11.35%. Over the course of the year, Novavax, Inc. shares have jumped approximately 192.92%. Shares of the company reached a 52-week high of $23.86 on 06/06/24 and a 52-week low of $3.53 on 02/05/24. A 50-day SMA is recorded $10.43, while a 200-day SMA reached $6.85. Nevertheless, trading volume fell to 10.8 million shares from 14.58 million shares the previous day.

Support And Resistance Levels for Novavax, Inc. (NVAX)

According to the 24-hour chart, there is a support level at 13.45, which, if violated, would cause prices to drop to 12.85. In the upper region, resistance lies at 14.51. The next price resistance is at 14.97. RSI (Relative Strength Index) is 49.54 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.44, which suggests the price will decrease in the coming days. Percent R is at 90.74%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Most Popular